{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:33:10Z","timestamp":1790677990019,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1213\/ane.0b013e3181b92201","type":"journal-article","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T03:21:17Z","timestamp":1255576877000},"page":"1395-1402","source":"Crossref","is-referenced-by-count":51,"title":["Acute Methadone Treatment Reduces Myocardial Infarct Size via the \u03b4-Opioid Receptor in Rats During Reperfusion"],"prefix":"10.1213","volume":"109","author":[{"given":"Eric R.","family":"Gross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett J.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210902","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.36076\/ppj.2008\/11\/S63","article-title":"Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.","volume":"11","author":"Manchikanti","year":"2008","journal-title":"Pain Physician"},{"key":"R2-10-20210902","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2004.01.072","article-title":"Coronary artery disease and opioid use.","volume":"93","author":"Marmor","year":"2004","journal-title":"Am J Cardiol"},{"key":"R3-10-20210902","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1006\/jmcc.1997.0454","article-title":"Ischemic preconditioning and morphine-induced cardioprotection involve the delta-opioid receptor in the intact rat heart.","volume":"29","author":"Schultz","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"R4-10-20210902","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/01.RES.84.12.1396","article-title":"Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels.","volume":"84","author":"Liang","year":"1999","journal-title":"Circ Res"},{"key":"R5-10-20210902","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0026-895X(25)09932-8","article-title":"Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.","volume":"45","author":"Raynor","year":"1994","journal-title":"Mol Pharmacol"},{"key":"R6-10-20210902","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0005-2736(89)90456-2","article-title":"Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproteronol.","volume":"987","author":"Ventura","year":"1989","journal-title":"Biochem Biophys Acta"},{"key":"R7-10-20210902","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1006\/bbrc.1996.0156","article-title":"Tissue distribution of opioid receptor gene expression in the rat.","volume":"218","author":"Wittert","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"R8-10-20210902","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1021\/jm00168a028","article-title":"Design of peptidomimetic delta opioid receptor antagonists using the message-address concept.","volume":"33","author":"Portoghese","year":"1990","journal-title":"J Med Chem"},{"key":"R9-10-20210902","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.CIR.103.2.290","article-title":"Morphine mimics preconditioning via free radical signals and mitochondrial K(ATP) channels in myocytes.","volume":"103","author":"McPherson","year":"2001","journal-title":"Circulation"},{"key":"R10-10-20210902","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00000542-200502000-00020","article-title":"Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors.","volume":"102","author":"Zhang","year":"2005","journal-title":"Anesthesiology"},{"key":"R11-10-20210902","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/bja\/84.5.608","article-title":"Fentanyl reduces infarction but not stunning via delta-opioid receptors and protein kinase C in rats.","volume":"84","author":"Kato","year":"2000","journal-title":"Br J Anaesth"},{"key":"R12-10-20210902","doi-asserted-by":"crossref","first-page":"H2744","DOI":"10.1152\/ajpheart.00918.2004","article-title":"Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway.","volume":"288","author":"Gross","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R13-10-20210902","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00000542-200410000-00017","article-title":"Remifentanil preconditioning protects against ischemic injury in the intact rat heart.","volume":"101","author":"Zhang","year":"2004","journal-title":"Anesthesiology"},{"key":"R14-10-20210902","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/jpet.103.064667","article-title":"Acute aspirin treatment abolishes, whereas acute ibuprofen treatment enhances morphine-induced cardioprotection: role of 12-lipoxygenase.","volume":"310","author":"Gross","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-10-20210902","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cardiores.2005.12.019","article-title":"Ligand triggers of classical preconditioning and postconditioning.","volume":"70","author":"Gross","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R16-10-20210902","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(25)13074-7","article-title":"Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.","volume":"277","author":"Knapp","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R18-10-20210902","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/01.RES.0000122392.33172.09","article-title":"Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.","volume":"94","author":"Gross","year":"2004","journal-title":"Circ Res"},{"key":"R19-10-20210902","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/jpet.108.138008","article-title":"Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.","volume":"326","author":"Obame","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R21-10-20210902","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/01.CIR.0000121422.85989.BD","article-title":"Morphine-tolerant mice exhibit a profound and persistent cardioprotective phenotype.","volume":"109","author":"Peart","year":"2004","journal-title":"Circulation"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e3181b92201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:34:51Z","timestamp":1786113291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200911000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181b92201","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1166938.629032","asserted-by":"object"}]},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}